These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 28340484)

  • 1. Engineering of layered, lipid-encapsulated drug nanoparticles through spray-drying.
    Sapra M; Mayya YS; Venkataraman C
    Colloids Surf B Biointerfaces; 2017 Jun; 154():178-185. PubMed ID: 28340484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of precursor solvent properties on matrix crystallinity and drug release rates from nanoparticle aerosol lipid matrices.
    Pawar AA; Chen DR; Venkataraman C
    Int J Pharm; 2012 Jul; 430(1-2):228-37. PubMed ID: 22469694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preparation and characterization of solid lipid nanoparticles of norcantharidin].
    Tian HY; Zhai GX
    Zhong Yao Cai; 2007 Sep; 30(9):1146-8. PubMed ID: 18236763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of critical supersaturation solubility ratio for predicting diameters of dry particles prepared by air-jet atomization of solutions.
    Sapra M; Ugrani S; Mayya YS; Venkataraman C
    J Colloid Interface Sci; 2017 Aug; 500():172-181. PubMed ID: 28410542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and evaluation of raloxifene-loaded solid dispersion nanoparticle by spray-drying technique without an organic solvent.
    Tran TH; Poudel BK; Marasini N; Chi SC; Choi HG; Yong CS; Kim JO
    Int J Pharm; 2013 Feb; 443(1-2):50-7. PubMed ID: 23318367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid-drug-conjugate (LDC) solid lipid nanoparticles (SLN) for the delivery of nicotine to the oral cavity - Optimization of nicotine loading efficiency.
    Ding Y; Nielsen KA; Nielsen BP; Bøje NW; Müller RH; Pyo SM
    Eur J Pharm Biopharm; 2018 Jul; 128():10-17. PubMed ID: 29545120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dry hybrid lipid-silica microcapsules engineered from submicron lipid droplets and nanoparticles as a novel delivery system for poorly soluble drugs.
    Simovic S; Heard P; Hui H; Song Y; Peddie F; Davey AK; Lewis A; Rades T; Prestidge CA
    Mol Pharm; 2009; 6(3):861-72. PubMed ID: 19358600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nano and microparticle engineering of water insoluble drugs using a novel spray-drying process.
    Schafroth N; Arpagaus C; Jadhav UY; Makne S; Douroumis D
    Colloids Surf B Biointerfaces; 2012 Feb; 90():8-15. PubMed ID: 22019455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and characterization of spray dried inhalable powders containing chitosan nanoparticles for pulmonary delivery of isoniazid.
    Pourshahab PS; Gilani K; Moazeni E; Eslahi H; Fazeli MR; Jamalifar H
    J Microencapsul; 2011; 28(7):605-13. PubMed ID: 21793647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategic approaches for improving entrapment of hydrophilic peptide drugs by lipid nanoparticles.
    Yuan H; Jiang SP; Du YZ; Miao J; Zhang XG; Hu FQ
    Colloids Surf B Biointerfaces; 2009 May; 70(2):248-53. PubMed ID: 19185474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Encapsulation of Rifampicin in a solid lipid nanoparticulate system to limit its degradation and interaction with Isoniazid at acidic pH.
    Singh H; Bhandari R; Kaur IP
    Int J Pharm; 2013 Mar; 446(1-2):106-11. PubMed ID: 23410991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microwave-assisted formulation of solid lipid nanoparticles loaded with non-steroidal anti-inflammatory drugs.
    Shah RM; Eldridge DS; Palombo EA; Harding IH
    Int J Pharm; 2016 Dec; 515(1-2):543-554. PubMed ID: 27789371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols.
    Park CW; Li X; Vogt FG; Hayes D; Zwischenberger JB; Park ES; Mansour HM
    Int J Pharm; 2013 Oct; 455(1-2):374-92. PubMed ID: 23820131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of Box-Behnken design for preparation of levofloxacin-loaded stearic acid solid lipid nanoparticles for ocular delivery: Optimization, in vitro release, ocular tolerance, and antibacterial activity.
    Baig MS; Ahad A; Aslam M; Imam SS; Aqil M; Ali A
    Int J Biol Macromol; 2016 Apr; 85():258-70. PubMed ID: 26740466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of novel spray-dried polymeric particles for controlled pulmonary drug delivery.
    Beck-Broichsitter M; Schweiger C; Schmehl T; Gessler T; Seeger W; Kissel T
    J Control Release; 2012 Mar; 158(2):329-35. PubMed ID: 22063006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and pharmacokinetics of solid lipid nanoparticles loaded with pueraria flavones.
    Guan Q; Guan Q; Lin T; Yin J
    J Control Release; 2011 Nov; 152 Suppl 1():e25-6. PubMed ID: 22195890
    [No Abstract]   [Full Text] [Related]  

  • 17. A single-step aerosol process for in-situ surface modification of nanoparticles: Preparation of stable aqueous nanoparticle suspensions.
    Sapra M; Pawar AA; Venkataraman C
    J Colloid Interface Sci; 2016 Feb; 464():167-74. PubMed ID: 26615512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and characterisation of novel spray-dried nano-structured para-aminosalicylic acid particulates for pulmonary delivery: impact of ammonium carbonate on morphology, chemical composition and solid state.
    Gad S; Tajber L; Corrigan OI; Healy AM
    J Pharm Pharmacol; 2012 Sep; 64(9):1264-74. PubMed ID: 22881439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid lipid nanoparticles for encapsulation of hydrophilic drugs by an organic solvent free double emulsion technique.
    Becker Peres L; Becker Peres L; de Araújo PHH; Sayer C
    Colloids Surf B Biointerfaces; 2016 Apr; 140():317-323. PubMed ID: 26764112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of the combinative particle size reduction technology H 42 to produce fast dissolving glibenclamide tablets.
    Salazar J; Müller RH; Möschwitzer JP
    Eur J Pharm Sci; 2013 Jul; 49(4):565-77. PubMed ID: 23587645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.